We are pleased to present the final agenda for the EFF Spring Virtual Summit.
The EFF Spring Virtual Summit will be a virtual meeting featuring the latest data from Stellar, our phase 1b/2 study in Ush2A mediated syndrome and retinitis pigmentosa as well as a panel discussion with expert clinical and patient perspectives and include interactive sessions related to the data, clinical and patient perspectives.
Here is the exciting program for the EFF Spring Summit 2021
Timetable – Thursday 15 April 2021
Welcome to the webinar
Presented by: Daniel de Boer, CEO, ProQR Therapeutics
Time: 17:00 CET / 11:00 EST
Daniel de Boer will open the EFF Spring Virtual Summit.
Presented by: Aniz Girach, Chief Medical Officer, ProQR Therapeutics
Time: 17:05 CET / 11:05 EST
Aniz Girach, CMO ProQR, will present a short update on the status of the ProQR Usher Syndrome program, including the outcome from the recent clinical milestone.
For a more detailed presentation on the recent Stellar clinical trial results of the QR-421a program for USH2A mediated Usher syndrome and retinitis pigmentosa, please watch (listen to) the video below.
On our YouTube channel you can navigate through the video using the timestamp links in the description.
Panel discussion on Usher clinical trials and the IRD community perspective
Dr. Paul Yang, Krista Vasi and Mani Iyer have been invited to the panel discussion on Usher syndrome clinical trials and the IRD community to answer all the questions the audience may have. What is the current state of clinical research in Usher syndrome? What is the patients’ perspective on current clinical research?
Make sure to pre-submit all your questions here!
Speaker: Jennifer Pluim
Time: 18:25 CET / 12:25 EST
If you want to join, please register for EFF updates to receive the webinar details.Skip back to main navigation